Brain cancer cells can be ‘reprogrammed’ to stop them from spreading
Peer-Reviewed Publication
Updates every hour. Last Updated: 7-Nov-2025 21:11 ET (8-Nov-2025 02:11 GMT/UTC)
Scientists have found a way to stop brain cancer cells spreading by essentially ‘freezing’ a key molecule in the brain.
Researchers developed a deep learning-based multimodal prognostic model that shows strong potential to improve disease-free survival prediction and enable personalized treatment in locally advanced cervical cancer.
CRISPR gene-editing machinery could transform medicine but is difficult to get into tissues and disease-relevant cells. New delivery system loads CRISPR machinery inside spherical nucleic acid (SNA) nanoparticles. Particles entered cells three times more effectively, tripled gene-editing efficiency, and decreased toxicity compared to current delivery methods.
Bladder cancer (BLCA) is one of the most prevalent malignancies of the urinary system, prone to recurrence, metastasis, and drug resistance. Its complex biological characteristics underscore the need to explore the molecular mechanisms underlying various aspects of BLCA tumorigenesis, while concurrently identifying novel therapeutic targets.
Scientists at Ben-Gurion University of the Negev have discovered that human cells operate a sophisticated, synchronized traffic control system that actively monitors nutrient availability and precisely controls cellular energy balance and blood sugar levels. This finding challenges long-held assumptions about how cells sense and respond to changing nutrient levels—and offers a promising new target for treating diabetes and cancer.
An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialised immune cells. The discovery, published in Immunity, could pave the way for more precise and personalised cancer immunotherapies.